fbpx
Skip to main content

Understanding Fentanyl & Nitazene Risks: A Guide for Opioid Users

This leaflet educates opioid users about the risks of Fentanyl and Nitazene contamination. It provides vital information on recognizing overdose symptoms, safer drug use practices, and accessing naloxone.

Size

A6

Pages

6

Price

£0.32 each
Cover and inside pages of an opioid,  Fentanyl,  and nitazene overdose leaflet

Some street drugs have been contaminated with the synthetic opioids fentanyl and nitazenes. These include heroin, illicit Oxycodone pills, Xanax powders, and synthetic cannabis (spice). 

Fentanyl and nitazenes are much stronger than heroin and have led to increased deaths caused by overdose.

The advice in this leaflet will help users of heroin or other opioid-style drugs to reduce the chances of overdosing.

This resource provides users with the following essential information on how to recognise and respond to potential opiate overdoses, with a particular focus on harm reduction:

  • How to recognise an opiate overdose: Learn to identify the signs
  • How to respond to an overdose: Know what to do
  • Strategies in how to reduce the risk of harm: Discover tips for safer drug use
  • How to get hold of naloxone: Where to source naloxone in your area

You can order printed versions of this resource or go to our harm reduction section to use the information on your website or printed materials.




  • All payments are processed by Shopify Secure, and use SSL encryption.
  • During checkout you wil be given the option to pay by card or receive an invoice.

Free sample

Try before you buy. Contact us for a full PDF sample of this resource.

Can't find what you need?

We can write and design a bespoke resource for your organisation.

Substance misuse resources

A range of harm reduction and drug & alcohol awareness booklets, leaflets and posters

Alcohol

Cannabis

Cocaine

Ecstasy

Mephedrone

Drug mix

Ketamine

New drugs

We supply resources to:
NHS logo
addaction logo
Lancaster university logo

Ask us a question

Name *
Organisation
Your email *
Your question